NCT07526259 Comparative Evaluation of Novel 3D Tunneling Technique Versus Modified Coronally Advanced Tunnel (MCAT) With Connective Tissue Graft in the Management of Multiple RT2 Gingival Recession
| NCT ID | NCT07526259 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Gingival Recession |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2025-05-10 |
| Primary Completion | 2027-01-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2025-05-10 with a primary completion date of 2027-01-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Defects associated with severe interdental hard and soft tissue loss are challenging to the periodontist, mainly due to the increased avascular surface and the reduced interproximal periosteal bed. Reports on the surgical techniques used to address recession type 2 or 3 defects mostly showed statistics on the mid-facial root coverage that yielded outcomes that do not encompass coverage of the interdental exposed root surface which highlights areas of controversy in their use for papilla reconstruction. Several case reports and clinical studies have shown encouraging results, but the long-term data are not available in the literature yet. The novel 3D tunneling (3DT) method achieved significant clinical improvement with long term stability in a recent case series. However, additional research is needed to validate 3DT for its routine clinical use. Moreover, the 3DT method achieved a decrease in the lingual recession depth which should be pointed out that the technique also addresses lingual recession.
Eligibility Criteria
Inclusion Criteria: * Buccal and lingual multiple adjacent recession defects classified as Cairo et al RT2. * Age ≥18 years * Full mouth plaque index score less than 20% O'Leary et al. 1972 * Patients with healthy systemic condition * Clinical indication and/or patient request for root coverage Exclusion Criteria: * Patients with systemically compromised health * Periodontal surgical treatment during the previous 24 months in the involved site * Pregnant or lactating mothers * Smokers * Non-compliant patients * Restored teeth * Non-carious cervical lesion
Frequently Asked Questions
Who can join the NCT07526259 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Gingival Recession. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07526259 currently recruiting?
Yes, NCT07526259 is actively recruiting participants. Visit ClinicalTrials.gov or contact Cairo University to inquire about joining.
Where is the NCT07526259 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07526259 clinical trial?
NCT07526259 is sponsored by Cairo University. The trial plans to enroll 36 participants.